Increased Total Revenue
Total revenue for the quarter was $388.7 million, an increase of 4% year-over-year.
SHOP Occupancy Growth
SHOP occupancy increased 210 basis points year-over-year to 81.5%, marking the fourth consecutive quarter of occupancy growth.
Successful Debt Refinancing
Completed a $1 billion refinancing of the Vertex Pharmaceuticals' headquarters and issued $375 million of senior secured notes, leading to no debt maturities until 2028.
Medical Office and Life Science Leasing Success
Completed approximately 86,000 square feet of leasing at weighted average rents of 9% above prior rents with an average term of nearly 7 years.
Asset Sale Proceeds
Year-to-date, sold 44 properties for $396 million, with additional agreements to sell 38 properties for $237 million.